
Chardan Healthcare Acquisition 2 Corp.
Chardan Healthcare Acquisition 2 Corp. (CHAQ) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
chaq · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Shell Companies · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Chardan Healthcare Acquisition 2 Corp.You CHAQ | — | N/A | — | — |
Distoken Acquisition Corporation DIST | $90M | 1045.76x | +184.4% | $0.01 |
DP Cap Acquisition Corp I DPCS | $91M | 47.46x | -87.1% | $0.23 |
GCT Semiconductor Holding, Inc. GCTS | $153M | N/A | — | -$0.82 |
Global Partner Acquisition Corp II GPAC | $90M | N/A | — | -$2.13 |
Good Works II Acquisition Corp. GWII | $90M | N/A | — | -$0.03 |
IG Acquisition Corp. IGAC | $102M | 9.78x | -97.3% | $1.00 |
Industry Average 3 peers with valid PE | — | 367.67x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Chardan Healthcare Acquisition 2 Corp. (CHAQ) measures how much investors pay for each dollar of the company's trailing earnings. CHAQ's current PE ratio of N/A is calculated by dividing its stock price of $8.41 by its TTM earnings per share of —.
Frequently asked questions
CHAQ pe ratio · 6 questionsCHAQ's current PE ratio is N/A as of 2026-06-09, based on a stock price of $8.41 and TTM EPS of —. Data sourced from Financial Modeling Prep via CHAQ's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Chardan Healthcare Acquisition 2 Corp. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09